Commitments and Contingencies

9 Months Ended

Sep. 30, 2020

Commitments And Contingencies Disclosure [Abstract]

18.	Commitments and Contingencies

Legal proceedings

In the normal course of business, the Company may become involved in legal disputes regarding various litigation matters. The Company records a loss contingency if the information available indicates that it is probable that a liability has been incurred at the date of the financial statements and the amount of loss can be reasonably estimated. As of September 30, 2020, in the opinion of management, no claims meet the criteria to record a loss contingency.

Lease commitments

The Company leases various facilities, under non-cancelable finance and operating leases, which expire at various dates through September 2027.

Maturities of lease liabilities:

Year ending December 31,	Operating Leases		Finance Leases
2020 (remaining three months)	$	941	$	235
2021		3,576		950
2022		3,019		5,389
2023		2,911		11,128
2024		2,489		—
Thereafter		8,049		—
Total lease payments	$	20,985	$	17,702
Imputed interest		2,175		3,207
Obligations recognized	$	18,810	$	14,495

Purchase commitments

The following table reflects the Company’s future non-cancellable minimum purchase commitments for inventory as of September 30, 2020:

	Total		2020 (remaining three months)		2021		2022		2023		2024		Thereafter
Purchase commitments	$	99,993	$	69,732	$	30,185	$	38	$	38	$	—	$	—
Total	$	99,993	$	69,732	$	30,185	$	38	$	38	$	—	$	—

In 2018, the Company signed an agreement with Rose Lifescience Inc. (“Rose”) for distribution and marketing of product in Quebec in exchange for a minimum fee of $384 per annum for an initial term of five years, and agreed to purchase the lesser of 2,000 Kg per year or 40% of the production of Cannabis at a rate of 115% of cost of goods sold from the Rose facility. In September 2020, the Company signed an amendment to this agreement and the estimated compensation fee is approximately $10,350 through 2023. As there is no firm commision fee commitment, it is excluded from the above schedule. Compensation fee expense is recorded as incurred.

In 2018, the Company entered into a Product and Trademark License Agreement with Docklight LLC, a related party (refer to Note 22), to use certain intellectual property rights in exchange for payment of royalty depending upon specified percentage of licensed product net sales. As the purchase commitment is an undeterminable variable amount, it is excluded from the above schedule.

Other commitments

The Company has payments on the ABG finance liability (refer to Note 11), convertible notes (refer to Note 12) and the Senior Facility (refer to Note 13) as follows:

	Total		2020 (remaining three months)		2021		2022		2023		2024		Thereafter
ABG finance liability	$	7,500	$	—	$	1,500	$	1,500	$	1,500	$	1,500	$	1,500
Convertible notes, principal and interest		546,251		5,938		23,750		23,750		492,813		—		—
Senior Facility, principal and interest		55,483		1,268		5,071		49,144		—		—		—
Portugal construction commitments		4,927		4,927
Total	$	614,161	$	12,133	$	30,321	$	74,394	$	494,313	$	1,500	$	1,500